Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Galecto_Biotech> ?p ?o }
Showing triples 1 to 31 of
31
with 100 triples per page.
- Galecto_Biotech abstract "Galecto Biotech is a Swedish biotechnology company that has developed a galectin-3 inhibitor that would prevent fibrosis. The galectin-3 inhibitor, TD139, has the potential to treat many diseases due to its involvement in many key biological pathways such as cell differentiation, cell growth, and apoptosis. Galecto Biotech is using this inhibitor to treat idiopathic pulmonary fibrosis (IPF), which is a progressive, irreversible and ultimately fatal lung disease that has poor prognosis and no effective therapies. Transforming growth factor is a major mediator of fibrosis and galectin-3 expression is highly upregulated in patients with idiopathic pulmonary fibrosis. TD139 galectin-3 inhibitor, reduces the transforming growth factor (TGF)-β signalling, ultimately showing a strong anti-fibrotic potential that may provide a novel treatment for idiopathic pulmonary fibrosis.".
- Galecto_Biotech wikiPageID "41213882".
- Galecto_Biotech wikiPageLength "1973".
- Galecto_Biotech wikiPageOutDegree "17".
- Galecto_Biotech wikiPageRevisionID "702954891".
- Galecto_Biotech wikiPageWikiLink Apoptosis.
- Galecto_Biotech wikiPageWikiLink Biotechnology.
- Galecto_Biotech wikiPageWikiLink Category:Biotechnology_companies.
- Galecto_Biotech wikiPageWikiLink Category:Biotechnology_companies_of_Sweden.
- Galecto_Biotech wikiPageWikiLink Cell_growth.
- Galecto_Biotech wikiPageWikiLink Cellular_differentiation.
- Galecto_Biotech wikiPageWikiLink Downregulation_and_upregulation.
- Galecto_Biotech wikiPageWikiLink Fibrosis.
- Galecto_Biotech wikiPageWikiLink Galectin-3.
- Galecto_Biotech wikiPageWikiLink Idiopathic_pulmonary_fibrosis.
- Galecto_Biotech wikiPageWikiLink Prognosis.
- Galecto_Biotech wikiPageWikiLink Transforming_growth_factor.
- Galecto_Biotech wikiPageWikiLinkText "Galecto Biotech".
- Galecto_Biotech wikiPageUsesTemplate Template:Orphan.
- Galecto_Biotech wikiPageUsesTemplate Template:Reflist.
- Galecto_Biotech subject Category:Biotechnology_companies.
- Galecto_Biotech subject Category:Biotechnology_companies_of_Sweden.
- Galecto_Biotech hypernym Company.
- Galecto_Biotech type Company.
- Galecto_Biotech comment "Galecto Biotech is a Swedish biotechnology company that has developed a galectin-3 inhibitor that would prevent fibrosis. The galectin-3 inhibitor, TD139, has the potential to treat many diseases due to its involvement in many key biological pathways such as cell differentiation, cell growth, and apoptosis.".
- Galecto_Biotech label "Galecto Biotech".
- Galecto_Biotech sameAs Q17083953.
- Galecto_Biotech sameAs m.0zdm6zv.
- Galecto_Biotech sameAs Q17083953.
- Galecto_Biotech wasDerivedFrom Galecto_Biotech?oldid=702954891.
- Galecto_Biotech isPrimaryTopicOf Galecto_Biotech.